The trademark application was filed by SWISS PHARMA INTERNATIONAL AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on September 29, 2025, and still open for oppositions.
The application was filed in English (Italian was selected as the second language).